13C葡萄糖呼气试验可准确识别1型糖尿病患者的胰岛素抵抗
本研究以44例体成分各异的1型糖尿病成人为对象,连续进行高胰岛素-正常血糖钳夹(HEC)及两次13C葡萄糖呼气试验(13C-GBT),评估呼气13CO2相对基线的变化值(Δ13CO2)对胰岛素抵抗(IR)的识别能力。结果显示正常血糖条件下Δ13CO2与钳夹M值强相关(r=0.74,P<.001),识别IR的AUC为0.81,最佳切点为≤5.8 δ‰。
要点
- 正常血糖条件下Δ13CO2与钳夹M值强相关(r=0.74,P<.001)。
- Δ13CO2识别IR(M值<4.9 mg/kg/min)的AUC为0.81(95%CI .68-.94,P<.001)。
- Δ13CO2识别IR的最佳切点为≤5.8 δ‰。
核心结论
- 在正常血糖条件下,13C-GBT可准确识别合并胰岛素抵抗的1型糖尿病患者,提示其有潜力作为有价值的无创指标。
研究设计与样本
- 在44例体成分各异的1型糖尿病成人中连续进行40 mU/m2/min高胰岛素-正常血糖钳夹(HEC)及两次13C葡萄糖呼气试验(13C-GBT):正常血糖加胰岛素团注和不加团注的高血糖。
- 以HEC为参考方法,计算基于糖化血红蛋白(HbA1c)、高血压和腰围的估计葡萄糖处置率(eGDR)并与13C-GBT比较。
主要发现
- 平均葡萄糖处置率(M值)为5.9 ± 3.1 mg/kg/min,平均正常血糖Δ13CO2为6.4 ± 2.1 δ‰,eGDR中位数为5.9 [4.3-9.8] mg/kg/min。
- 高血糖Δ13CO2与M值无相关性,而正常血糖Δ13CO2与M值强相关(r=0.74,P<.001)。
- M值与eGDR的相关性较弱(Spearman's rho=0.63,P<.001)。
- 线性回归显示Δ13CO2与M值相关,校正年龄、性别和HbA1c后adjusted R²=0.52,B=1.16,95%CI .80-1.52,P<.001。
- Δ13CO2识别IR(M值<4.9 mg/kg/min)的受试者工作特征曲线下面积为0.81(95%CI .68-.94,P<.001),最佳切点为≤5.8 δ‰。
关键数值与推荐
- Δ13CO2识别IR(M值<4.9 mg/kg/min)的最佳切点为≤5.8 δ‰,AUC为0.81(95%CI .68-.94,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study investigated whether the delta-over-baseline of exhaled 13CO2 (Δ13CO2), generated from a 13C glucose breath test (13C-GBT), measured insulin resistance (IR) in people with type 1 diabetes, using the hyperinsulinemic-euglycemic clamp (HEC) as a reference method. The secondary objective was to compare the 13C-GBT with the estimated glucose disposal rate (eGDR). METHODS: A 40 mU/m2/min HEC and 2 separate 13C-GBTs (euglycemic with insulin bolus and hyperglycemic without bolus) were consecutively performed in 44 adults with type 1 diabetes with varying body compositions. eGDR was calculated based on hemoglobin A1c (HbA1c), presence of hypertension, and waist circumference. RESULTS: The mean glucose disposal rate (M-value) was 5.9 ± 3.1 mg/kg/min and mean euglycemic Δ13CO2 was 6.4 ± 2.1 δ‰, while median eGDR was 5.9 [4.3-9.8] mg/kg/min. The hyperglycemic Δ13CO2 did not correlate with the M-value, while the euglycemic Δ13CO2 and the M-value correlated strongly (r = 0.74, P < .001). The correlation between M-value and eGDR was more moderate (Spearman's rho = 0.63, P < .001). Linear regression showed an association between Δ13CO2 and M-value, adjusted for age, sex, and HbA1c ]adjusted R² = 0.52, B = 1.16, 95% confidence interval (CI) .80-1.52, P < .001]. The area under the receiver-operator characteristics curve for Δ13CO2 to identify subjects with IR (M-value < 4.9 mg/kg/min) was 0.81 (95% CI .68-.94, P < .001). The optimal cut-off for Δ13CO2 to identify subjects with IR was ≤ 5.8 δ‰. CONCLUSION: Under euglycemic conditions, the 13C-GBT accurately identified individuals with type 1 diabetes and concurrent IR, suggesting its potential as a valuable noninvasive index. Clinical Trial Identifier: NCT04623320.
引用
- Mertens J, Roosens L, Braspenning R, et al. The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes. J Clin Endocrinol Metab. 2025. PMID: 38487831. doi:10.1210/clinem/dgae175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。